In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis

Miltefosine was the first oral compound approved for visceral leishmaniasis chemotherapy, and its efficacy against Leishmania donovani has been well documented. Leishmania amazonensis is the second most prevalent species causing cutaneous leishmaniasis and the main etiological agent of diffuse cutan...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Coelho, Adriano C., Trinconi, Cristiana T., Costa, Carlos H. N., Uliana, Silvia R. B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2014
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102453/
https://ncbi.nlm.nih.gov/pubmed/25033218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0002999
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi